Format

Send to

Choose Destination
Ann Dermatol. 2012 May;24(2):126-35. doi: 10.5021/ad.2012.24.2.126. Epub 2012 Apr 26.

Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease.

Author information

1
Department of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany.

Abstract

Chronic inflammatory skin diseases such as atopic dermatitis, psoriasis or rosacea are very common. Although their exact pathogenesis is not completely understood all three diseases are characterized by dysregulation of cutaneous innate immunity. Cathelicidin LL-37 is an important effector molecule of innate immunity in the skin and atopic dermatitis, psoriasis or rosacea show defects in cathelicidin expression, function or processing. In atopic dermatitis, cathelicidin induction might be disturbed resulting in defective antimicrobial barrier function. In contrast, psoriasis is characterized by overexpression of cathelicidin. However to date it is unclear whether pro- or anti-inflammatory functions of cathelicidin predominate in lesional skin in psoriasis. In rosacea, cathelicidin processing is disturbed resulting in peptide fragments causing inflammation, erythema and telangiectasias. In this review, the current evidence on the role of cathelicidin LL-37 in the pathogenesis of inflammatory skin diseases will be outlined. As cathelicidin LL-37 might also serve as a future treatment target potential novel treatment strategies for those diseases will be discussed.

KEYWORDS:

Atopic dermatitis; Cathelicidin LL-37; Innate immunity; Psoriasis; Rosacea; Vitamin D

Supplemental Content

Full text links

Icon for Korean Dermatological Association Icon for PubMed Central
Loading ...
Support Center